Adenovirus-mediated overexpression of an N-terminally truncated, constitutively active fragment of ChREBP similar to endogenous ChREBP-beta in the liver lowers circulating glucose, insulin, and triglyceride levels while increasing hepatic de novo lipogenesis and steatosis. This evidence concerns the gene MLXIPL and steatosis.